Discover key insights from West Pharmaceutical Services' Q4 2024 earnings call, highlighting growth in GLP-1 elastomers, biologics, and HVP components.

The S&P 500 advanced 1.0% on Thursday, Feb. 13, as an executive order deferred the possible implementation of reciprocal ...

CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total ...

ASX health stocks have fallen this week as Chemist Warehouse hits the bourse through its merger with Sigma Healthcare.

West Pharmaceutical Services Inc . (NYSE:WST) reported its fourth-quarter 2024 earnings, surpassing analyst expectations with an earnings per share (EPS) of $1.82 compared to the forecasted $1.72.

Eli Lilly and Company (NYSE: LLY) is one of two pharmaceutical stocks behind the weight loss drug craze that has impacted the ...

Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

Shares of mobile app advertising platform AppLovin (NASDAQ: APP) jumped 34.2% in the morning session after the company ...

Nvidia’s data-center sales could disappoint in the first half of the year but that's not a reason to sell the stock, ...

West Pharmaceutical Services stock sank Thursday after the company issued a full-year outlook that missed analysts’ expectations. Shares plunged 31% to $222.46, putting them on pace for their worst ...